Psoriatic Arthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Psoriatic Arthritis Pipeline Drugs Market Overview

Psoriatic arthritis is a form of arthritis that affects some people who have psoriasis. Symptoms include swollen fingers and toes, foot pain, and lower back pain. Risk factors include age, family history, and psoriasis. Treatment includes NSAIDs, immunosuppressants, and surgery. The Psoriatic Arthritis pipeline drugs market research report provides comprehensive information on the therapeutics under development for Psoriatic Arthritis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases.

Psoriatic Arthritis Pipeline Drugs Market Segmentation by Targets

The key targets of the Psoriatic Arthritis pipeline drugs market are Tumor Necrosis Factor, Interleukin 23 Subunit Alpha, Interleukin 17A, Interleukin 12 Subunit Beta, Lymphotoxin Alpha, Non Receptor Tyrosine Protein Kinase TYK2, and Interleukin 17F.

Psoriatic Arthritis Pipeline Drugs Market Analysis, by Targets

For more target insights into the Psoriatic Arthritis pipeline drugs market, download a free report sample

Psoriatic Arthritis Pipeline Drugs Market Segmentation by Mechanisms of Action

The key mechanisms of action of the Psoriatic Arthritis pipeline drugs market are Tumor Necrosis Factor Inhibitor, Interleukin 23 Subunit Alpha Inhibitor, Interleukin 17A Inhibitor, Interleukin 12 Subunit Beta Inhibitor, Lymphotoxin Alpha Inhibitor, Non Receptor Tyrosine Protein Kinase TYK2 Inhibitor, Interleukin 17F Inhibitor, Phosphodiesterase 4 Inhibitor, and Tyrosine Protein Kinase JAK1 Inhibitor.

Psoriatic Arthritis Pipeline Drugs Market Analysis, by Mechanisms of Action

For more mechanisms of action insights into the Psoriatic Arthritis pipeline drugs market, download a free report sample

Psoriatic Arthritis Pipeline Drugs Market Segmentation by Routes of Administration

The key routes of administration in the Psoriatic Arthritis pipeline drugs market are subcutaneous, intravenous, oral, topical, intramuscular, and parenteral.

Psoriatic Arthritis Pipeline Drugs Market Analysis, by Routes of Administration

For more routes of administration insights into the Psoriatic Arthritis pipeline drugs market, download a free report sample

Psoriatic Arthritis Pipeline Drugs Market Segmentation by Molecule Types

The key molecule types in the Psoriatic Arthritis pipeline drugs market are Monoclonal Antibody, Small Molecule, Fusion Protein, Biologic, Monoclonal Antibody Conjugated, Cell Therapy, and Recombinant Protein.

Psoriatic Arthritis Pipeline Drugs Market Analysis, by Molecule Types

For more molecule type insights into the Psoriatic Arthritis pipeline drugs market, download a free report sample

Psoriatic Arthritis Pipeline Drugs Market - Competitive Landscape

Some of the leading companies in the Psoriatic Arthritis pipeline drugs market are Galapagos NV, Johnson & Johnson, Bioviz Technologies Pvt Ltd, Jiangsu Hengrui Medicine Co Ltd, 3SBio Inc, AbbVie Inc, Amgen Inc, and Avesthagen Ltd.

Psoriatic Arthritis Pipeline Drugs Market Analysis, by Companies

To know more about the companies in the Psoriatic Arthritis pipeline drugs market, download a free report sample

Psoriatic Arthritis Pipeline Drugs Market Report Overview

Scope

• The pipeline guide provides a snapshot of the global therapeutic landscape of Psoriatic Arthritis (Musculoskeletal Disorders).
• The pipeline guide reviews pipeline therapeutics for Psoriatic Arthritis (Musculoskeletal Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
• The pipeline guide covers pipeline products based on several development stages ranging from pre-registration to discovery and undisclosed stages.
• The pipeline guide features descriptive drug profiles for the pipeline products, including product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
• The pipeline guide reviews key companies involved in Psoriatic Arthritis (Musculoskeletal Disorders) therapeutics and enlists all their major and minor projects.
• The pipeline guide evaluates Psoriatic Arthritis (Musculoskeletal Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
• The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
• The pipeline guide reviews latest news related to pipeline therapeutics for Psoriatic Arthritis (Musculoskeletal Disorders)

Reasons to Buy

• Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
• Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
• Find and recognize significant and varied types of therapeutics under development for Psoriatic Arthritis (Musculoskeletal Disorders).
• Classify potential new clients or partners in the target demographic.
• Develop tactical initiatives by understanding the focus areas of leading companies.
• Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
• Formulate corrective measures for pipeline projects by understanding Psoriatic Arthritis (Musculoskeletal Disorders) pipeline depth and focus of Indication therapeutics.
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
• Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.